Emerging research highlights the power of physiological peptides and dual agonists to transform therapeutic approaches for metabolic diseases. These novel compounds offer the unique capacity to simultaneously activate multiple targets, circumventing the drawbacks of traditional single-target treatments. By modulating metabolic signaling, they ca… Read More